The evaluation and treatment of Paget's disease of bone

Best Pract Res Clin Rheumatol. 2020 Jun;34(3):101506. doi: 10.1016/j.berh.2020.101506. Epub 2020 Apr 11.

Abstract

Paget's disease of bone is a localized skeletal disorder, which is more common in England and in countries to which the English migrated. In recent decades, the prevalence in most countries has decreased. A family history of the disorder is present in approximately 15% of patients. Patients may be asymptomatic and may be diagnosed accidently as a consequence of an elevated serum alkaline phosphatase level or a finding on an x-ray or nuclear bone scan. The diagnosis is made by x-ray but nuclear bone scans define the extent of the disease. Salmon calcitonin and bisphosphonate drugs have proven effective, but by far, the most effective therapy is a single 5 mg intravenous infusion of zoledronic acid. This can normalize alkaline phosphatase levels for up to 6.5 years. A variety of gene mutations may predispose individuals to develop the disease but environmental factors such as measles virus likely play an important role.

Keywords: Bone pain; Deformity; Drug therapy; Familial; Surgery.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Bone and Bones
  • Diphosphonates* / therapeutic use
  • Humans
  • Osteitis Deformans* / diagnostic imaging
  • Osteitis Deformans* / drug therapy
  • Radiography
  • Radionuclide Imaging

Substances

  • Diphosphonates